Dermatopathology for the surgical pathologist: A pattern based approach to the diagnosis of inflammatory skin disorders (Part I)

Advances in Anatomic Pathology

Volumn 15, Issue 2, 2008, Pages 76-96

  Brinster, Nooshin K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Interface; Lichenoid; Psoriasiform; Spongiotic; Subcorneal dermatoses; Subepidermal dermatoses; Suprabasilar dermatoses; Vacuolar

Indexed keywords

BULLOUS DERMATITIS; BULLOUS PEMPHIGOID; CLINICAL ASSESSMENT; CLINICAL FEATURE; DERMATITIS; DERMATITIS HERPETIFORMIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; EPIDERMIS HYPERPLASIA; EPIDERMOLYSIS BULLOSA ACQUISITA; HISTOPATHOLOGY; HUMAN; LICHENOID ERUPTION; LINEAR IMMUNOGLOBULIN A DERMATOSIS; MUCOUS MEMBRANE PEMPHIGOID; PANNICULITIS; PHLEBITIS; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN BIOPSY; SKIN DISEASE; SKIN INFLAMMATION; SPONGIOTIC DERMATITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VACUOLAR INTERFACE DERMATITIS; VASCULITIS; DERMATOLOGY; INFLAMMATION; PATHOLOGY;

DERMATOLOGY; HUMANS; INFLAMMATION; PATHOLOGY, SURGICAL; SKIN DISEASES;

EID: 43749085064     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e3181664e8d     Document Type: Review

References (51)

1. Ackerman AB. Histologic Diagnosis of Inflammatory Skin Diseases. 1st ed. Philadelphia: Lea & Febiger; 1978.
2. Ackerman AB, Chongchitnant N, Sanchez J, et al. Histologic Diagnosis of Inflammatory Skin Diseases: An Algorithmic Method Based on Pattern Analysis. 2nd ed. Baltimore, MD: Williams & Wilkins; 1997.
3. Ackerman AB, Boer A, Bennin B, et al. Histologic Diagnosis of Inflammatory Skin Diseases: An Algorithmic Method Based on Pattern Analysis. 3rd ed. New York, NY: Ardor Scribendi; 2005.
4. Lipozencic J, Wolf R. Atopic dermatitis: an update and review of the literature. Dermatol Clin. 2007;25:605-612.
5. Brasch J, Burgard J, Sterry W. Common pathogenetic pathways in allergic and irritant contact dermatitis. J Invest Dermatol. 1992;98:166-170.
6. McKee PH, Calonje JE, Granter SR. Pathology of the Skin. 3rd ed. St Louis, MO: Elsevier Mosby; 2005.
7. Elder DE, Elenitsas R, Johnson BL, et al, eds. Lever's Histopathology of the Skin. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
8. Jobling R. Psoriasis. BMJ. 2007;334:953-954.
9. Barr RJ, Young EM Jr. Psoriasiform and related papulosquamous disorders. J Cutan Pathol. 1985;12:412-425.
10. Soeprono FF. Histologic criteria for the diagnosis of pityriasis rubra pilaris. Am J Dermatopathol. 1986;8:277-283.
11. Fox BJ, Odom RB. Papulosquamous diseases: a review. J Am Acad Dermatol. 1985;12:597-624.
12. Schofield JK, Tatnall FM, Leigh IM. Recurrent erythema multiforme: clinical features and treatment in a large series of patients. Br J Dermatol. 1993;128:542-545.
13. Lyell A. A review of toxic epidermal necrolysis in Britain. Br J Dermatol. 1967;79:662-671.
14. LeBoit PE. Interface dermatitis. How specific are its histopathologic features? Arch Dermatol. 1993;129:1324-1328.
15. Boyd AS, Neldner KH. Lichen planus. J Am Acad Dermatol. 1991;25:593-619.
16. Ellis FA. Histopathology of lichen planus based on analysis of one hundred biopsy specimens. J Invest Dermatol. 1967;48:143-148.
17. Kowalczyk AP, Anderson JE, Borgwardt JE, et al. Pemphigus sera recognize conformationally sensitive epitopes in the amino-terminal region of desmoglein-1. J Invest Dermatol. 1995;105:147-152.
18. Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. 2nd ed. Philadelphia: Mosby-Yearbook; 2007.
19. Ladhani S. Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus. FEMS Immunol Med Microbiol. 2003;39:181-189.
20. Reid LH, Weston WL, Humbert JR. Staphylococcal scalded skin syndrome. Adult onset in a patient with deficient cell-mediated immunity. Arch Dermatol. 1974;109:239-241.
21. Sneddon IB, Wilkinson DS. Subcorneal pustular dermatosis. Br J Dermatol. 1956;68:385-394.
22. Baker H, Ryan TJ. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol. 1968;80:771-793.
23. Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol. 1991;127:1333-1338.
24. Amagai M, Karpati S, Prussick R, et al. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest. 1992;90:919-926.
25. Harrist TJ, Mihm MC. Cutaneous immunopathology. The diagnostic use of direct and indirect immunofluorescence techniques in dermatologic disease. Hum Pathol. 1979;10:625-653.
26. Hu Z, Bonifas JM, Beech J, et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet. 2000;24:61-65.
27. Sakuntabhai A, Ruiz-Perez V, Carter S, et al. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nat Genet. 1999;21:271-277.
28. Grover RW. Transient acantholytic dermatosis. Arch Dermatol. 1970;101:426-434.
29. Asbrink E, Hovmark A. Clinical variations in bullous pemphigoid with respect to early symptoms. Acta Derm Venereol. 1981;61:417-421.
30. Gammon WR, Briggaman RA, Inman AO III, et al. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol. 1984;82:139-144.
31. Hardy KM, Perry HO, Pingree GC, et al. Benign mucous membrane pemphigoid. Arch Dermatol. 1971;104:467-475.
32. Bernard P, Prost C, Lecerf V, et al. Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. J Invest Dermatol. 1990;94:630-635.
33. Bhol KC, Dans MJ, Simmons RK, et al. The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4. J Immunol. 2000;165:2824-2829.
34. Domloge-Hultsch N, Anhalt GJ, Gammon WR, et al. Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder. Arch Dermatol. 1994;130:1521-1529.
35. Hunter GA. Clinical manifestations of the porphyrias: a review. Australas J Dermatol. 1979;20:120-122.
36. Elder GH. Alcohol intake and porphyria cutanea tarda. Clin Dermatol. 1999;17:431-436.
37. Lobato MN, Berger TG. Porphyria cutanea tarda associated with the acquired immunodeficiency syndrome. Arch Dermatol. 1988;124:1009-1010.
38. Wolff K, Honigsmann H, Rauschmeier W, et al. Microscopic and fine structural aspects of porphyrias. Acta Derm Venereol Suppl (Stockh). 1982;100:17-28.
39. Roenigk HH Jr, Ryan JG, Bergfeld WF. Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Arch Dermatol. 1971;103:1-10.
40. Gammon WR, Briggaman RA, Woodley DT, et al. Epidermolysis bullosa acquisita - A pemphigoid-like disease. J Am Acad Dermatol. 1984;11:820-832.
41. Woodley DT, Burgeson RE, Lunstrum G, et al. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest. 1988;81:683-687.
42. Nieboer C, Boorsma DM, Woerdeman MJ, et al. Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients. Br J Dermatol. 1980;102:383-392.
43. Olansky AJ, Briggaman RA, Gammon WR, et al. Bullous systemic lupus erythematosus. J Am Acad Dermatol. 1982;7:511-520.
44. Pedro SD, Dahl MV. Direct immunofluorescence of bullous systemic lupus erythematosus. Arch Dermatol. 1973;107:118-120.
45. Gammon WR, Woodley DT, Dole KC, et al. Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen. J Invest Dermatol. 1985;84:472-476.
46. Kumar V, Jarzabek-Chorzelska M, Sulej J, et al. Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis. Clin Immunol. 2001;98:378-382.
47. van der Meer JB. Granular deposits of immunoglobulins in the skin of patients with dermatitis herpetiformis. An immunofluorescent study. Br J Dermatol. 1969;81:493-503.
48. Wojnarowska F, Marsden RA, Bhogal B, et al. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol. 1988;19:792-805.
49. Pothupitiya GM, Wojnarowska F, Bhogal BS, et al. Distribution of the antigen in adult linear IgA disease and chronic bullous dermatosis of childhood suggests that it is a single and unique antigen. Br J Dermatol. 1988;118:175-182.
50. Zambruno G, Kanitakis J. Linear IgA dermatosis with IgA antibodies to type VII collagen. Br J Dermatol. 1996;135:1004-1005.
51. Zone JJ, Taylor TB, Meyer LJ, et al. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol. 1998;110:207-210.